Possible perspectives for using phytoadaptogens in post-COVID period

Abstract

Currently the new coronavirus infection caused by SARS-CoV-2 continues to be a serious public health problem. The fight against this virus includes a continuous search not only for the optimal treatment of the disease itself, but also for the full rehabilitation of patients in the postcovid period. Given the clinical variability and the need for one-stage correcting functions of many systems and organs after this disease, it seems appropriate to use in the recovery of these patients plant adaptogens, which have multiple effects on the body. Our review demonstrates the phytoadaptogen uniqueness in their mild multidirectional impact on neuroendocrine-immune regulation, which leads to the correcton of physiological functions disturbed during the disease. Plantl adaptogens were shown to help reduce pathological changes in the lungs, have antihypoxic and antioxidant effects, exhibit psychotropic and neuroprotective properties, influence on carbohydrate metabolism and cardiovascular system activity, support immune homeostasis and have a general adaptogenic effect. In addition, these biologics enhance the effectiveness of the entire complex therapy and allow neutralizing the side effects of the jointly taken synthetic drugs. To achieve the optimal effect of phytoadaptogens in post-COVID-19 patients it is preferable to use adaptogenic plant combinations, taking into account the mutually reinforcing pharmacological plant properties and leading pathognomonic syndromes. The phytoadaptogen use in the post-COVID-19 patient treatment will contribute to their psychoemotional stabilization, immunoresistance increase, pathological change regression in organs and tissues, mental and physical performance improvement, which will eventually improve the life quality of recovered from COVID-19 patients and preserve public health.